Ascitic Fluid Calprotectin as an Accurate Diagnostic Marker for Spontaneous Bacterial Peritonitis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-10

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Spontaneous bacterial peritonitis (SBP) is an infection of the ascitic fluid in patients with liver cirrhosis and portal hypertension. There is no obvious surgical cause as perforation or intraabdominal inflammatory focus as abscess. Up to 30% of the ascitic patients will develop SBP.

SBP is attributed to immune dysfunction, bacterial translocation, circulatory dysfunction and inflammatory status. SBP is diagnosed by ascitic fluid analysis . SBP was defined as polymorphonuclear leucocyte count (PMN) \>250/mm3 in ascitic fluid, . Not all cases are associated with positive ascitic fluid cultures.

There are variants of ascitic fluid infections as culture-negative neutrocytic ascites, monomicrobial non-neutrocytic bacterascites, polymicrobial bacterascites and secondary bacterial peritonitis.

The advent of the SBP carries a poor prognosis where the hospital mortality ranged from 10 to 50%. As a consequence, any patient with SBP should be assessed for liver transplantation. Immediate treatment with antibiotics and IV albumin should be initiated.

Studies were conducted on alternatives of the ascitic PMN count as high sensitivity C-reactive protein (hsCRP), serum procalcitonin, urinary lipocalin, ascitic lactoferrin, homocysteine and fecal or ascitic calprotectin.

The gold standard test for SBP is ascitic fluid analysis with measurement of the PMN. It is useful for the diagnosis and monitoring of treatment. The culture of the ascitic fluid may be positive if was done correctly .

There is a variant of SBP that is called culture-negative neutrocytic ascites. It is characterized by elevated ascitic fluid PMN but the culture is negative. It is managed exactly as classic SBP. Such cases would be missed if cultures were not done The manual PMN counting is time consuming, laborious and required some experience to avoid intra- and inter-observer variability. So, a simple rapid bedside test would be useful clinically.

Calprotectin is acute-phase inflammatory protein that is released from the PMN. Calprotectin has anti-proliferative and antimicrobial properties. Calprotectin is used clinically widespread in the diagnosis and monitoring treatment of inflammatory bowel disease .

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Calprotectin for Rapid Diagnostic Infection Spontaneous of Ascites

NCT02857101

Rapid Diagnosis of Spontaneous Infection of Ascitic Fluid

UNKNOWN

Predictors of Spontaneous Bacterial Peritonitis Among Patients with Cirrhosis

NCT06884306

Cirrhosis

NOT_YET_RECRUITING

Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases

NCT01200082

Hepatobiliary Diseases

TERMINATED

Hyperbilirubinemia in Acute Appendicitis as a Predictor of Perforation

NCT00528138

Perforated Appendicitis

COMPLETED

CMV Reactivation in Acute Necrotizing Pancreatitis

NCT05898048

Acute Necrotizing Pancreatitis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spontaneous Bacterial Peritonitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

case

people who have spontaneous bacterial peritonitis

Group Type ACTIVE_COMPARATOR

ascitic fluid calprotectin

Intervention Type DIAGNOSTIC_TEST

ascitic fluid calprotectin

control

people who donot have spontaneous bacterial peritonitis

Group Type ACTIVE_COMPARATOR

ascitic fluid calprotectin

Intervention Type DIAGNOSTIC_TEST

ascitic fluid calprotectin

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ascitic fluid calprotectin

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\-

The patients were divided into two groups:

1. Non-SBP group: it included 25 patients with cirrhotic ascites without clinical or laboratory evidence of SBP.
2. SBP group: it included 25 patients with cirrhotic ascites with SBP. They were diagnosed by positive ascitic fluid bacterial culture, an increase in PMNLs count in ascites (\>250 cells/mm3) and without any intra-abdominal source of infection.

Exclusion Criteria

* (1) Cirrhotic patients with and without SBP receiving antibiotics in last 1 week.

(2) Recent abdominal surgery (\<3 months). (3) abdominal malignancy \[hepatocellular carcinoma (HCC), colorectal carcinoma, gastric carcinoma, pancreatic carcinoma, cholangiocarcinoma\].

(4) Intra-abdominal infected lesions, such as abscess, appendicitis, cholecystitis, and pancreatitis.

(5) History of inflammatory bowel disease (Crohn's disease, ulcerative colitis).

(6) patients with heart failure (HF), hematological, and autoimmune disorders were excluded.

Eligible Sex

ALL

Accepts Healthy Volunteers

No